Precision immunotherapy targeting immune dysregulation improves organ dysfunction in sepsis patients. Learn more about this ...

In atopic dermatitis, the first interleukin-22 inhibitor to reach late clinical trials is showing uncommonly broad suppression of biomarkers associated with disease activity.

As of Friday, December 19, Werewolf Therapeutics, Inc.’s HOWL share price has surged by 9.05%, which has investors questioning if this is right time to sell.

Lab-grown hearts with immune cells develop atrial fibrillation after chronic inflammation, offering a new way to test ...

A new study published in the Journal of Alzheimer’s Disease revealed that clinical periodontitis was not linked to the onset ...

Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating ...

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated DoseResults Support Advancement of the Program into Phase 2 DevelopmentCombination of ...

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass. Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 ...

The Oklahoma City Thunder travel on the road to face the Golden State Warriors on Tuesday. It's the second matchup of the season between the squads. Last time, OKC blew out the veteran squad on Nov.